Trade Summary

4 days ago, Sarchi Christopher, serving as Chief Commercial Officer at Replimune Group, Inc. (REPL), sold 12,000 shares at $9.24 per share, for a total transaction value of $110,880.00. Following this transaction, Sarchi Christopher now holds 180,962 shares of REPL.

This sale represents a 6.22% decrease in Sarchi Christopher's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 1, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 (accepted Jun 3, 8:30 PM ET), 3 days after the trade was made.

Replimune Group, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.